Literature DB >> 23364765

Physiology: Beating stroke.

Neil Savage.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23364765     DOI： 10.1038/493S12a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial.

Authors:  Sanjiv M Narayan; David E Krummen; Kalyanam Shivkumar; Paul Clopton; Wouter-Jan Rappel; John M Miller
Journal:  J Am Coll Cardiol       Date:  2012-07-18       Impact factor: 24.094

2.  Apixaban versus warfarin in patients with atrial fibrillation.

Authors:  Christopher B Granger; John H Alexander; John J V McMurray; Renato D Lopes; Elaine M Hylek; Michael Hanna; Hussein R Al-Khalidi; Jack Ansell; Dan Atar; Alvaro Avezum; M Cecilia Bahit; Rafael Diaz; J Donald Easton; Justin A Ezekowitz; Greg Flaker; David Garcia; Margarida Geraldes; Bernard J Gersh; Sergey Golitsyn; Shinya Goto; Antonio G Hermosillo; Stefan H Hohnloser; John Horowitz; Puneet Mohan; Petr Jansky; Basil S Lewis; Jose Luis Lopez-Sendon; Prem Pais; Alexander Parkhomenko; Freek W A Verheugt; Jun Zhu; Lars Wallentin
Journal:  N Engl J Med       Date:  2011-08-27       Impact factor: 91.245

3.  Subclinical atrial fibrillation and the risk of stroke.

Authors:  Jeff S Healey; Stuart J Connolly; Michael R Gold; Carsten W Israel; Isabelle C Van Gelder; Alessandro Capucci; C P Lau; Eric Fain; Sean Yang; Christophe Bailleul; Carlos A Morillo; Mark Carlson; Ellison Themeles; Elizabeth S Kaufman; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

4.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

5.  Centerline tracking for quantification of reverse structural remodeling of the pulmonary veins following cardiac ablation therapy.

Authors:  Maryam E Rettmann; Mia S Gunawan; David R Holmes; Jerome F Breen; Douglas L Packer; Richard A Robb
Journal:  Acad Radiol       Date:  2012-08-11       Impact factor: 3.173

6.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.

Authors:  Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman
Journal:  Eur Heart J       Date:  2006-03-09       Impact factor: 29.983

7.  Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Karen L Furie; Larry B Goldstein; Gregory W Albers; Pooja Khatri; Ron Neyens; Mintu P Turakhia; Tanya N Turan; Kathryn A Wood
Journal:  Stroke       Date:  2012-08-02       Impact factor: 7.914
  7 in total
  3 in total

Review 1.  Proarrhythmic and Torsadogenic Effects of Potassium Channel Blockers in Patients.

Authors:  Mark McCauley; Sharath Vallabhajosyula; Dawood Darbar
Journal:  Card Electrophysiol Clin       Date:  2016-03-22

Review 2.  Small molecule inhibitors in the treatment of cerebral ischemia.

Authors:  Jerry J Flores; Yang Zhang; Damon W Klebe; Tim Lekic; Weiling Fu; John H Zhang
Journal:  Expert Opin Pharmacother       Date:  2014-02-04       Impact factor: 3.889

3.  Disruption of cardiac cholinergic neurons enhances susceptibility to ventricular arrhythmias.

Authors:  Christiane Jungen; Katharina Scherschel; Christian Eickholt; Pawel Kuklik; Niklas Klatt; Nadja Bork; Tim Salzbrunn; Fares Alken; Stephan Angendohr; Christiane Klene; Janos Mester; Nikolaj Klöcker; Marieke W Veldkamp; Udo Schumacher; Stephan Willems; Viacheslav O Nikolaev; Christian Meyer
Journal:  Nat Commun       Date:  2017-01-27       Impact factor: 14.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.